Logo-bi
Review

1. Nanomaterials as Non-viral siRNA Delivery Agents for Cancer Therapy
Sanjay Singh*
Bioimpacts. 2013;3(2): 53-65. doi: 10.5681/bi.2013.007
PMCID: PMC3713871     PMID: 23878788     Scopus ID: 84881502609    
Article
PDF
XML
Cited By:
38
7
0
Editorial

2. The challenges of green nanotechnology
Miguel de la Guardia*
Bioimpacts. 2014;4(1): 1-2. doi: 10.5681/bi.2014.009
PMCID: PMC4005277     PMID: 24790892     Scopus ID: 84900478943    
Article
PDF
XML
Cited By:
10
3
0
Editorial

3. Nanocosmetics: benefits and risks
Javad Shokri*
Bioimpacts. 2017;7(4): 207-208. doi: 10.15171/bi.2017.24
PMCID: PMC5801531     PMID: 29435427     Scopus ID: 85040988305    
Article
PDF
Full Text
XML
Cited By:
17
1
15
Review

4. Engineered nanoparticle bio-conjugates toxicity screening: The xCELLigence cells viability impact
Clarence S Yah* ORCID, Geoffrey S. Simate
Bioimpacts. 2020;10(3): 195-203. doi: 10.34172/bi.2020.24
PMCID: PMC7416007     PMID: 32793442     Scopus ID: 85089711934    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
4
2
5
The impact of bio-nanomaterials XCELLigence-cytotoxicity testing. A non-invasive in-vitro monitoring process that mimics exact continuous cellular bio-responses. However, to expand and affirm consumer safety concerns of bio-nanomaterials, additional XCELLigence data is required for bio-nanomaterials toxicity protocols and methodological development.

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge